Aster DM Quality Care Ltd. (ASTERDM) fundamentals
Aster DM Quality Care Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as ASTERDM (ISIN INE914M01019). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Aster DM Quality Care Ltd. does
Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes oncology (AIIO), cardiac sciences, neurosciences, gastro sciences, integrated liver care, multi-organ transplant, orthopedics, obstetrics and gynecology, and pediatrics and neonatology. Its pharmacy offers various product categories, including prescription, OTC drugs, personal care and hygiene, feminine care, baby care, wellness, sports nutrition, surgical and disposables, and medical devices. Its labs deliver diagnostic services covering biochemistry, microbiology, hematology, clinical pathology, histopathology and cytogenetics.
Valuation and market data
| Last close | ₹647.00 |
|---|---|
| Market capitalisation | ₹36,746 crore |
| Enterprise value | ₹38,818 crore |
| P/E (TTM) | 86.04 |
| Price to book | 7.60 |
| Price to sales (TTM) | 4.36 |
| Book value per share | ₹85.11 |
| Dividend yield | 46.37% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Feb 26 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹2,771 crore | ₹374 crore | ₹268 crore | 5.20 |
| Mar 2025 | ₹8,059 crore | ₹6,288 crore | ₹6,209 crore | 124.67 |
| Mar 2024 | ₹2,086 crore | ₹209 crore | ₹157 crore | 3.15 |
| Mar 2023 | ₹1,584 crore | ₹182 crore | ₹173 crore | 3.48 |
| Mar 2022 | ₹1,199 crore | ₹90 crore | ₹90 crore | 1.81 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 53.8% |
|---|---|
| Foreign institutions (FII) | 12.3% |
| Mutual funds | 20.8% |
| Other domestic institutions | 0.9% |
| Retail and others | 12.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.